Brady W. Dougan
CIK: 0001878020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Humacyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 11, 2026HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
0 shares- - Nov 16, 2025HUMA
Humacyte, Inc.
Award(A)IndirectStock Options (right to buy)
311.1K shares- - Aug 20, 2025HUMA
Humacyte, Inc.
Sale(S)Indirect591.7K shares at avg. $1.58$935K - Aug 19, 2025HUMA
Humacyte, Inc.
Sale(S)Indirect1.1M shares at avg. $1.63$1.8M - Aug 18, 2025HUMA
Humacyte, Inc.
Sale(S)Indirect549.4K shares at avg. $1.83$1.0M - Jun 12, 2025HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
0 shares- - Jan 21, 2025HUMA
Humacyte, Inc.
Award(A)IndirectStock Options (right to buy)
1.1M shares- - Dec 19, 2024HUMA
Humacyte, Inc.
Award(A)IndirectStock Options (right to buy)
525 shares- - Nov 20, 2024HUMA
Humacyte, Inc.
Sale(S)Indirect261.4K shares at avg. $4.40$1.2M - Nov 19, 2024HUMA
Humacyte, Inc.
Purchase(P)Indirect1.8K shares at avg. $4.44$8K - Nov 19, 2024HUMA
Humacyte, Inc.
Sale(S)Indirect427.5K shares at avg. $4.34$1.9M - Nov 18, 2024HUMA
Humacyte, Inc.
Sale(S)Indirect811.2K shares at avg. $4.44$3.6M - Sep 10, 2024HUMA
Humacyte, Inc.
Sale(S)Indirect288.7K shares at avg. $5.23$1.5M - Sep 9, 2024HUMA
Humacyte, Inc.
Sale(S)Indirect157.7K shares at avg. $5.42$855K - Aug 29, 2024HUMA
Humacyte, Inc.
Purchase(P)Indirect1.2K shares at avg. $6.54$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 0 | - | - | Direct |
| Nov 16, 2025 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 311,100 | - | - | Indirect |
| Aug 20, 2025 | HUMA Humacyte, Inc. | Sale(S) | 591,685 | $1.58 | $934,862 | Indirect |
| Aug 19, 2025 | HUMA Humacyte, Inc. | Sale(S) | 1,100,000 | $1.63 | $1,793,000 | Indirect |
| Aug 18, 2025 | HUMA Humacyte, Inc. | Sale(S) | 549,360 | $1.83 | $1,005,329 | Indirect |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 0 | - | - | Direct |
| Jan 21, 2025 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 1,130,311 | - | - | Indirect |
| Dec 19, 2024 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 525 | - | - | Indirect |
| Nov 20, 2024 | HUMA Humacyte, Inc. | Sale(S) | 261,369 | $4.40 | $1,150,024 | Indirect |
| Nov 19, 2024 | HUMA Humacyte, Inc. | Purchase(P) | 1,797 | $4.44 | $7,979 | Indirect |
| Nov 19, 2024 | HUMA Humacyte, Inc. | Sale(S) | 427,459 | $4.34 | $1,855,172 | Indirect |
| Nov 18, 2024 | HUMA Humacyte, Inc. | Sale(S) | 811,172 | $4.44 | $3,601,604 | Indirect |
| Sep 10, 2024 | HUMA Humacyte, Inc. | Sale(S) | 288,674 | $5.23 | $1,509,765 | Indirect |
| Sep 9, 2024 | HUMA Humacyte, Inc. | Sale(S) | 157,704 | $5.42 | $854,756 | Indirect |
| Aug 29, 2024 | HUMA Humacyte, Inc. | Purchase(P) | 1,222 | $6.54 | $7,998 | Indirect |
1-15 of 15 transactions
About Dougan Brady W
Dougan Brady W (SEC CIK 0001878020) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA).
Signal8 holds 10 ownership filings by Dougan Brady W, all Form 4s, filed between Sep 3, 2024 and Jun 12, 2026. Those filings report 15 transactions, from Aug 29, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dougan Brady W's filings is in DURHAM, NC.
Recent filings by Dougan Brady W
- Jun 11, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
- Nov 16, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
- Aug 20, 2025: Open-market sale of HUMA shares (Form 4, code S).
- Aug 19, 2025: Open-market sale of HUMA shares (Form 4, code S).
- Aug 18, 2025: Open-market sale of HUMA shares (Form 4, code S).
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Kuznik Paul Brian, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director